SHPH
NASDAQ · Biotechnology
Shuttle Pharmaceuticals Hold
$4.07
-0.51 (-11.14%)
Open$4.61
Previous Close$4.58
Day High$4.61
Day Low$4.01
52W High$55.90
52W Low$2.58
Volume—
Avg Volume574.7K
Market Cap2.79M
P/E Ratio—
EPS$-5.71
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.31M | 2.94M | 3.37M |
| Net Income | 119.2K | 97.1K | 110.6K |
| Profit Margin | 3.6% | 3.3% | 3.3% |
| EBITDA | 181.4K | 163.4K | 177.0K |
| Free Cash Flow | 96.2K | 133.1K | 131.3K |
| Rev Growth | +15.9% | +11.7% | +12.8% |
| Debt/Equity | 0.66 | 0.73 | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |